RxDoctor Payments Data

Ellen de Moll, MD

Dermatology · New Canaan, CTNPI 1518349877

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $66,213 of the $102,551 with a category attached, or 64.6%. 25 manufacturers reported payments, led by UCB, Inc. at 49.6% of the total. 2025 is the largest year on record at $68,141, more than ten times the $228 reported in 2020. Among dermatology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$102,551in general payments, 2019–2025

Across 513 payments — averaging $199.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$51K
  • Galderma Laboratories, L.p.$31K
  • Sun Pharmaceutical Industries Inc.$8K
  • Incyte Corporation$3K
  • Takeda Pharmaceuticals U.S.A., Inc.$3K
  • AbbVie$1K
  • plus $6K from 19 others

What the payments were for

  • Consulting fees$15,83315%
  • Speaking & faculty fees$66,21365%
  • Travel & lodging$8,4868%
  • Food & beverage$11,50211%
  • Education$5181%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$102,551 in reported general payments places this provider in the 90th percentile of 222 dermatology providers in Connecticut.

See all dermatology providers in Connecticut

Medicare billing

Part B allowed, 2024
$114,360
Medicare patients
488
Services billed
1,467

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab11$173,868
Dupixent PenDupilumab25$92,995
Clobetasol Propionate83$3,428
Fluorouracil50$3,187
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc101$2,235
Calcipotriene12$2,212
Triamcinolone Acetonide127$1,870
Tacrolimus17$1,361
Ketoconazole105$1,236
Tretinoin17$1,220
Clindamycin Phosphate30$1,021
Betamethasone Dipropionate25$861
Desonide20$841
Minoxidil46$821
Metronidazole19$637

Paid to pharmacies, not to this prescriber.

Other dermatology in New Canaan

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →